| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
64,210,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
141 |
Avg
Vol: |
1,513,129 |
| 52
Week Range: |
$0.000001 - $0.238 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Infinity Pharmaceuticals is a clinical-stage biopharmaceutical company. Co. is focused on advancing eganelisib (IPI-549), an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma. The preclinical findings indicate that eganelisib may have the potential to treat various solid tumors and represents an additive or synergistic approach to restoring anti-tumor immunity in combination with other immunotherapies such as checkpoint inhibitors. Further, preclinical studies showed that eganelisib inhibits the regrowth of tumors that can occur following treatment with chemotherapy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
410,196 |
425,190 |
| Total Sell Value |
$0 |
$0 |
$28,714 |
$38,646 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
1 |
2 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Evnin Anthony B |
Director |
– • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,176,257 |
23,530 |
|
- |
|
| Lee Patrick Pak-Tin |
Director |
– • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,123,746 |
21,998 |
|
- |
|
| Perkins Adelene Q |
CFO,Treasurer and Secretary |
• – – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
177,927 |
177,927 |
|
- |
|
| Moss Franklin |
Director |
– • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
I/I |
11,049 |
3,683 |
|
- |
|
| Moss Franklin |
Director |
– • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
56,126 |
33,154 |
|
- |
|
| Holtzman Steven H |
CEO and Assistant Secretary |
• • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
I/I |
177,364 |
177,364 |
|
- |
|
| Holtzman Steven H |
CEO and Assistant Secretary |
• • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
229,820 |
18,729 |
|
- |
|
| Sato Vicki L |
Director |
– • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,051 |
11,051 |
|
- |
|
| Lander Eric S |
Director |
– • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
I/I |
61,887 |
61,887 |
|
- |
|
| Lander Eric S |
Director |
– • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
71,705 |
9,818 |
|
- |
|
| Tananbaum James B |
Director |
– • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,552,165 |
799,152 |
|
- |
|
| Levine Arnold J |
Director |
– • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
18,787 |
18,787 |
|
- |
|
| Burke Thomas Joseph |
Assistant Treasurer |
• – – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,306 |
10,306 |
|
- |
|
| Daniel D Ronald |
Director |
– • – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
13,261 |
13,261 |
|
- |
|
| Adams Julian |
President |
• – – |
2006-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
125,530 |
125,530 |
|
- |
|
| Neale Richard |
Vice President |
• – – |
2006-08-14 |
4 |
D |
$2.84 |
$2,437 |
D/D |
(858) |
39,635 |
|
- |
|
| Neale Richard |
Vice President |
• – – |
2006-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
64,493 |
|
- |
|
| Pigliucci Riccardo |
Former Chairman & CEO |
– – – |
2005-11-22 |
4 |
D |
$2.66 |
$51,322 |
D/D |
(19,294) |
653,463 |
|
- |
|
| Neale Richard |
Vice President |
• – – |
2005-08-31 |
4 |
D |
$3.15 |
$2,703 |
D/D |
(858) |
38,427 |
|
- |
|
| Harvey Daniel |
Vice President |
• – – |
2005-08-31 |
4 |
D |
$3.15 |
$2,161 |
D/D |
(686) |
31,628 |
|
- |
|
| Venuti Michael C |
Chief Scientific Officer |
• • – |
2005-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
200,000 |
|
- |
|
| Crouch Taylor |
President & COO |
• – – |
2005-01-26 |
4 |
D |
$4.20 |
$126,000 |
D/D |
(30,000) |
0 |
|
- |
|
| Harvey Daniel |
Vice PresidentOfficer |
• – – |
2005-01-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
32,000 |
|
- |
|
| Neale Richard |
Vice President |
• – – |
2004-08-04 |
4 |
D |
$4.81 |
$4,127 |
D/D |
(858) |
37,484 |
|
- |
|
| Regenass Urs |
Vice President |
• – – |
2004-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
44,000 |
|
- |
|
227 Records found
|
|
Page 8 of 10 |
|
|
